Jean-christophe Tellier
Ceo
Pharma
UCB
Slovakia
Biography
Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences) and of BIO (Biotechnology Industry Organization in the US) and of PhRMA (Pharmaceutical Research and Manufacturers of America). He is also VicePresident as well as a President-Elect of the Board of the European Federation of Pharmaceutical Associations (EFPIA), Chairman of the Innovation Board Sponsored Committee (EFPIA) and board member of the Innovative Medicines Initiative (IMI). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 25-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world.
Research Interest
Interested in pharmaceutical researches
